| Literature DB >> 36060693 |
Guillermo R Oviedo1,2, María Carbó-Carreté3,4, Myriam Guerra-Balic1, Nauris Tamulevicius5, Laura Esquius6, Joan Guàrdia-Olmos4,7,8, Casimiro Javierre9.
Abstract
Introduction: The genetic disorder causing Down syndrome (DS) affects the cardiorespiratory and hemodynamic parameters. When exercising, sufficient blood flow is necessary for active muscles. Cardiac output (Q) must be proportional to the peripheral requirements. In case the stroke volume (SV) is lower, the heart rate (HR) will increase further in order to maintain an adequate blood flow in the active territories (HR compensatory response). People with DS have a lower HR response to maximal exercise. Nevertheless, the response of the hemodynamic and cardiorespiratory parameters during the submaximal phases of maximal exercise was not well studied. Objective: to evaluate cardiorespiratory and hemodynamic parameters 1) during submaximal and 2) maximal metabolic treadmill test in individuals with and without DS.Entities:
Keywords: blood preasure; cardiorespirarory fitness; down syndrome; exercice; hemodymamics
Year: 2022 PMID: 36060693 PMCID: PMC9437284 DOI: 10.3389/fphys.2022.905795
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.755
Participants’ characteristics.
| Non-DS (n = 15) | DS (n = 15) |
| Effect size | |||||
|---|---|---|---|---|---|---|---|---|
| Characteristics | ||||||||
| Sex (male/female) | 12/3 | 12/3 | 1.000 | -- | ||||
| Age (years) | 27.3 | ± | 5.0 | 27.3 | ± | 5.0 | 1.000 | -- |
| Weight (kg) | 71.5 | ± | 9.9 | 66.6 | ± | 9.9 | 0.185 | 0.50 |
| Height (m) | 1.75 | ± | 0.09 | 1.56 | ± | 0.06 | <0.001 | 2.40 |
| BMI (kg/m2) | 23.3 | ± | 1.6 | 27.4 | ± | 4.3 | 0.002 | 1.28 |
values are mean ± standard deviation.
Abbreviations; DS (Down syndrome); BMI (body mass index).
Participants’ cardiorespiratory and hemodynamic values at rest.
| Non-DS (n = 15) | DS (n = 15) |
| Effect size | |||||
|---|---|---|---|---|---|---|---|---|
| Resting values | Resting values | |||||||
|
| ||||||||
| VE (L•min−1) | 10.1 | ± | 1.7 | 9.9 | ± | 2.9 | 0.720 | 0.13 |
| RER | 0.88 | ± | 0.04 | 0.85 | ± | 0.05 | 0.416 | 0.30 |
| RR (breath•min−1) | 18.3 | ± | 4.1 | 20.8 | ± | 6.4 | 0.162 | 0.52 |
| VT (L) | 0.50 | ± | 0.13 | 0.48 | ± | 0.11 | 0.171 | 0.51 |
| VEqO2 | 31.1 | ± | 4.8 | 29.2 | ± | 4.4 | 0.273 | 0.41 |
| VEqCO2 | 108.2 | ± | 6.1 | 106.7 | ± | 4.2 | 0.139 | 0.56 |
| PETO2 (mmHg) | 37.8 | ± | 5.7 | 34.8 | ± | 4.9 | 0.581 | 0.20 |
| VO2 (ml•kg−1•min−1) | 4.5 | ± | 0.9 | 5.0 | ± | 1.1 | 0.208 | 0.47 |
| VO2 (L•min−1) | 0.32 | ± | 0.06 | 0.33 | ± | 0.11 | 0.423 | 0.30 |
| VCO2 (L•min−1) | 0.28 | ± | 0.05 | 0.28 | ± | 0.15 | 0.368 | 0.33 |
|
| ||||||||
| Q (L•min−1) | 6.4 | ± | 2.8 | 6.5 | ± | 2.6 | 0.913 | 0.04 |
| Stroke Volume (ml) | 84.3 | ± | 22.7 | 75.0 | ± | 21.1 | 0.252 | 0.42 |
| SBP (mmHg) | 137.0 | ± | 26.6 | 119.5 | ± | 24.8 | 0.120 | 0.67 |
| DBP (mmHg) | 86.6 | ± | 16.6 | 78.8 | ± | 15.4 | 0.089 | 0.48 |
| MAP (mmHg) | 106.2 | ± | 19.9 | 94.3 | ± | 18.5 | 0.082 | 0.62 |
| SVR (dyn•s−1•cm−5) | 1,447.5 | ± | 531.1 | 1700.0 | ± | 494.4 | 0.086 | 0.49 |
| O2 pulse (ml•beat−1) | 4.37 | ± | 2.74 | 4.08 | ± | 2.78 | 0.773 | 0.10 |
| HR (beat•min−1) | 77.0 | ± | 14.2 | 83.0 | ± | 13.1 | 0.290 | 0.43 |
values are mean ± standard deviation.
Abbreviations: DS (Down syndrome); VE (minute ventilation); RER (respiratory exchange ratio); RR (respiratory rate); VT: tidal volume; VEqO2: ventilatory equivalent for O2; VEqCO2: ventilatory equivalent for CO2; PETO2 (end-tidal partial pressure for oxygen); VO2 (oxygen uptake); VCO2 (carbon dioxide production); Q (cardiac output); SBP (systolic blood pressure); DBP (diastolic blood pressure); MAP (mean arterial pressure); SVR (systemic vascular resistance); HR (heart rate).
p-value: between-group differences at rest.
Participants’ peak cardiorespiratory and hemodynamic values.
| Non-DS (n = 15) | DS (n = 15) |
| Effect size | |||||
|---|---|---|---|---|---|---|---|---|
| Peak values | Peak values | |||||||
|
| ||||||||
| VE (L•min−1) | 123.9 | ± | 23.3 | 53.7 | ± | 14.5 | <0.001 | 3.61 |
| RER | 1.14 | ± | 0.03 | 1.12 | ± | 0.03 | 0.043 | 0.77 |
| RR (breath•min−1) | 46.3 | ± | 7.4 | 42.0 | ± | 7.8 | 0.139 | 0.56 |
| VT (L) | 2.47 | ± | 0.59 | 1.15 | ± | 0.22 | <0.001 | 2.93 |
| VEqO2 | 33.9 | ± | 3.8 | 28.2 | ± | 2.6 | <0.001 | 1.75 |
| VEqCO2 | 27.8 | ± | 2.8 | 27.8 | ± | 2.3 | 0.992 | 0.00 |
| PETO2 (mmHg) | 112.4 | ± | 3.8 | 107.5 | ± | 3.0 | 0.001 | 1.42 |
| VO2 (ml•kg−1•min−1) | 51.6 | ± | 10.9 | 28.8 | ± | 6.7 | <0.001 | 2.53 |
| VO2 (L•min−1) | 3.73 | ± | 0.91 | 1.90 | ± | 0.44 | <0.001 | 2.55 |
| VCO2 (L•min−1) | 4.26 | ± | 0.98 | 2.12 | ± | 0.54 | <0.001 | 3.12 |
| VO2 max predicted (%) | 123.1 | ± | 16.3 | 77.9 | ± | 10.7 | <0.001 | 3.27 |
| Respiratory reserve (%) | 14.3 | ± | 9.6 | 55.5 | ± | 8.2 | <0.001 | 4.50 |
| Treadmill test duration (min) | 16.6 | ± | 2.0 | 12.5 | ± | 2.1 | <0.001 | 1.99 |
|
| ||||||||
| Q (L•min−1) | 20.2 | ± | 3.0 | 14.1 | ± | 3.6 | 0.002 | 1.32 |
| Stroke Volume (ml) | 113.2 | ± | 20.4 | 94.2 | ± | 22.9 | 0.030 | 0.87 |
| SBP (mmHg) | 188.4 | ± | 34.0 | 141.6 | ± | 22.7 | <0.001 | 1.56 |
| DBP (mmHg) | 106.0 | ± | 21.5 | 85.6 | ± | 17.2 | 0.016 | 0.97 |
| MAP (mmHg) | 141.6 | ± | 26.8 | 107.5 | ± | 22.0 | 0.001 | 1.36 |
| SVR (dyn•s−1•cm−5) | 794.4 | ± | 315.2 | 916.3 | ± | 463.8 | 0.431 | 0.30 |
| O2 pulse (ml•beat−1) | 20.4 | ± | 4.2 | 12.5 | ± | 2.5 | <0.001 | 1.96 |
| HR (beat•min−1) | 183.0 | ± | 7.1 | 150.0 | ± | 13.1 | <0.001 | 3.04 |
Note: values are mean ± standard deviation.
Abbreviations: DS (Down syndrome); VE (minute ventilation); RER (respiratory exchange ratio); RR (respiratory rate); VT: tidal volume; VEqO2: ventilatory equivalent for O2; VEqCO2: ventilatory equivalent for CO2; PETO2 (end-tidal partial pressure for oxygen); VO2 (oxygen uptake); VCO2 (carbon dioxide production); Q (cardiac output); SBP (systolic blood pressure); DBP (diastolic blood pressure); MAP (mean arterial pressure); SVR (systemic vascular resistance); HR (heart rate).
p-value: between-group differences for peak values.
FIGURE 1Cardiorespiratory and hemodynamic parameters in response to submaximal exercise in adults with and without Down syndrome. (A): Cardiorespiratory parameters; (B): Hemodynamic parameters. Abbreviations: DS (Down syndrome). Values are mean ± standard error. * Between-group differences (p < 0.050). ‡ Medium effect size. # Large effect size.
FIGURE 2Relationship between ventilation (VE; L/min) and carbon dioxide production (VCO2; L/min) during the submaximal phases of the treadmill test. Abbreviations: DS (Down syndrome).